GLP-1 medications offer promising benefits for obesity and diabetes patients, with studies showing reduced heart attack risk and potential applications for addiction treatment.

In the UK, anxiety, panic attacks and insomnia are not listed as possible side-effects for Ozempic, Wegovy or Mounjaro.

Vadodara: A six-month-old baby girl has tested positive for Covid-19 and is currently undergoing treatment at the state-run ...

A diabetes drug may soon double as a treatment for liver disease. Dapagliflozin, an SGLT-2 inhibitor typically used for type 2 diabetes, significantly improved liver inflammation and scarring in ...

Nearly 16 million Americans have the most deadly type of liver disease - metabolic dysfunction-associated steatohepatitis ...

Ozempic teeth” is a term used to describe the unexpected dental side effects of Ozempic, including bad breath, gum irritation ...

The Wall Street Journal reports on the expected FDA approval of lenacapavir and what it might mean for Gilead's future in the market. Other coverage of science and research-related news is on a ...

Weight-loss drugs like Ozempic and Wegovy are used by more than 15 million adults in the U.S., or 4.5% of the population.

Novo Nordisk's (NVO) weight loss drug semaglutide (Ozempic, Wegovy, Rybelsus) is linked to a rare eye condition called NAION ...

Many Americans struggle with being overweight, social stigmas still prevent people from talking to doctors and seeking ...

Alert follows 40 reports of pregnancy in women taking these weight-loss drugs such as Ozempic, Wegovy, and Mounjaro ...

An SGLT2 inhibitor helped improve metabolic dysfunction-associated steatohepatitis (MASH) in people with or without type 2 ...